Ohshiro, Takahito
Konno, Masamitsu
Asai, Ayumu
Komoto, Yuki
Yamagata, Akira
Doki, Yuichiro
Eguchi, Hidetoshi
Ofusa, Ken
Taniguchi, Masateru
Ishii, Hideshi
Funding for this research was provided by:
New Energy and Industrial Technology Development Organization
Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, JAPAN (21H01741, 19K07688, 18K16355, 18K14091, 15H05791, 19H00852, 17H04282)
JST-CREST (JPMJCR1666)
Princess Takamatsu Cancer Research Fund and the Kobayashi Foundation for Cancer Research
Article History
Received: 27 April 2021
Accepted: 15 September 2021
First Online: 29 September 2021
Competing interests
: M.K. has the following financial interests: Chugai Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.; Ono Pharmaceutical Co., Ltd.; and Merck Co., Ltd. H.I. has the following financial interests: partial institutional endowments were received from Hirotsu Bio Science, Inc.; Kinshukai Medical Corporation; IDEA Consultants, Inc.; Kyowakai Medical Corporation; and Unitech Co., Ltd. A.Y. and K.O. are employees of IDEA Consultants, Inc.